BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7754100)

  • 1. Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours.
    Stridsberg M; Eriksson B; Lundqvist G; Skogseid B; Wilander E; Oberg K
    Regul Pept; 1995 Jan; 55(2):119-31. PubMed ID: 7754100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet amyloid polypeptide-like immunoreactivity in human tissue and endocrine tumors.
    Bretherton-Watt D; Ghatei MA; Bloom SE; Williams S; Bloom SR
    J Clin Endocrinol Metab; 1993 Apr; 76(4):1072-4. PubMed ID: 8473384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors].
    Kianmanesh R; O'toole D; Sauvanet A; Ruszniewski P; Belghiti J
    J Chir (Paris); 2005; 142(3):132-49. PubMed ID: 16142076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet amyloid polypeptide/amylin messenger RNA and protein expression in human insulinomas in relation to amyloid formation.
    van Hulst KL; Oosterwijk C; Born W; Vroom TM; Nieuwenhuis MG; Blankenstein MA; Lips CJ; Fischer JA; Höppener JW
    Eur J Endocrinol; 1999 Jan; 140(1):69-78. PubMed ID: 10037255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemistry of neuroendocrine tumours.
    de Herder WW
    Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):33-41. PubMed ID: 17382264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of plasma chromogranin A in neuroendocrine tumours.
    Tomassetti P; Migliori M; Simoni P; Casadei R; De Iasio R; Corinaldesi R; Gullo L
    Eur J Gastroenterol Hepatol; 2001 Jan; 13(1):55-8. PubMed ID: 11204811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.
    Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G
    J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1.
    Peracchi M; Conte D; Gebbia C; Penati C; Pizzinelli S; Arosio M; Corbetta S; Spada A
    Eur J Endocrinol; 2003 Jan; 148(1):39-43. PubMed ID: 12534356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hCG and hCG subunits as tumour markers in patients with endocrine pancreatic tumours and carcinoids.
    Oberg K; Wide L
    Acta Endocrinol (Copenh); 1981 Oct; 98(2):256-60. PubMed ID: 6117168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery on neuroendocrine tumours.
    Akerström G; Hellman P
    Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):87-109. PubMed ID: 17382267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical staining for islet amyloid polypeptide in pancreatic endocrine tumors.
    Tomita T
    Islets; 2011; 3(6):344-51. PubMed ID: 21983096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical investigation of insulinomas for islet amyloid polypeptide and insulin: evidence for differential synthesis and storage.
    Williams AJ; Coates PJ; Lowe DG; McLean C; Gale EA
    Histopathology; 1992 Sep; 21(3):215-23. PubMed ID: 1356906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic cancer in rats and hamsters does not induce IAPP-related hyperglycaemia.
    Oosterwijk C; van Hulst KL; Visser CJ; Woutersen RA; Lips CJ; van den Tweel JG; Höppener JW
    Int J Cancer; 1997 Aug; 72(4):637-41. PubMed ID: 9259404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multimodal imaging of pancreatic neuroendocrine tumors].
    Müssig K; Bares R; Dudziak K; Horger M
    Rofo; 2008 May; 180(5):373-9. PubMed ID: 18464198
    [No Abstract]   [Full Text] [Related]  

  • 15. The ultimate biochemical diagnosis of endocrine pancreatic tumours in MEN-1.
    Oberg K; Skogseid B
    J Intern Med; 1998 Jun; 243(6):471-6. PubMed ID: 9681845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostics and treatment in functional pancreatic neuroendocrine tumours].
    Müssig K; Dudziak K; Horger M; Anlauf M; Goretzki PE
    Dtsch Med Wochenschr; 2011 Jun; 136(24):1319-30. PubMed ID: 21656454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No constant relationship between islet amyloid polypeptide (IAPP) and insulin expression in insulinomas.
    Nieuwenhuis MG; van Mansfeld AD; van Unnik JA; Berends MJ; Lips CJ
    Neth J Med; 1992 Dec; 41(5-6):264-71. PubMed ID: 1362976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
    Enoki S; Mitsukawa T; Takemura J; Nakazato M; Aburaya J; Toshimori H; Matsukara S
    Diabetes Res Clin Pract; 1992 Jan; 15(1):97-102. PubMed ID: 1541241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple endocrine neoplasia type 1.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
    Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
    J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.